SRF acquires pharmaceutical propellant business DuPont

SRF acquires pharmaceutical propellant business of DuPont

11:43 AM, 5th January 2015
SRF acquires pharmaceutical propellant business of DuPont

NEW DELHI, INDIA: SRF Limited has announced the acquisition of Global DuPont Dymel, the pharmaceutical propellant business of American chemical giant DuPont. In an all-cash deal, SRF would pay a consideration of $20 million for DuPont’s Fluorochemicals business, which is part of the performance chemicals segment that DuPont plans to hive off by mid-2015.

Under the transaction, DuPont would transfer the ‘Dymel’ brand to SRF as well as the technology and knowhow for setting up its own ‘current Good Manufacturing Practices’ (cGMP) facility for manufacturing its unique pharma grade propellants that do not emit ozone-depleting gases while delivering medications to patients.

In the long run, the access to the pharma segment allows SRF to move up the value chain and cater to the growing demand for the pharma grade HFC 134a, approved as a long-term environment friendly alternative propellant for a growing number of medical applications.

“This acquisition is in sync with our long-term strategy to move up the value chain and will enable us to enter the niche pharma product segment. The growth in the Metered Dose Inhalers (MDI) sector is expected to be reasonably robust in the years to come. This will also offer great synergy with our existing HFC plants going forward,” said Ashish Bharat Ram, Managing Director, SRF Ltd.

DuPont will supply SRF the product from its existing facility till SRF’s facility is approved. DuPont currently has a manufacturing facility for pharma grade HFA-134a in Texas which is in full compliance with the US Food and Drug Administration’s (US FDA) ‘current Good Manufacturing Practices’ (cGMP).

SRF Limited already has two plants for manufacture of technical grade of HFC 134a. Additionally, with the possibility of some drugs going off patent by 2019, it is likely that India will witness a significant growth in the demand of pharma grade of HFC 134a and SRF, as the only Indian supplier of the product, looks well positioned to reap the benefits, said a statement from the company on the acquisition that takes effect immediately.

 

© The Economic Times News 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Lubrizol completes acquisition of Warwick

CLEVELAND, US: The Lubrizol Corporation has completed the acquisition of Warwick Chemicals, a leading global developer, producer and supplie ...

Read more
China searches precious metals in Indian Ocean

BEIJING, CHINA: A Chinese submersible vessel has conducted its first deep dive in the Indian Ocean in search of rare metals. The project involves coll ...

Read more
New method to detect estrogen, could improve cancer research

TEXAS, US: Scientists at the Shimadzu Institute for Research Technologies and the Department of Chemistry and Biochemistry at The University of Texas ...

Read more
Hyosung to expand spandex production at China

SEOUL, SOUTH KOREA: South Korean textile and industrial materials maker Hyosung Corp will boost spandex production at its China plant, a step that wil ...

Read more
Agrium restarts potash production at Vanscoy facility, Canada

CALGARY, CANADA: Agrium Inc, major producer and distributor of agricultural products and services in North America, South America and Australia, has r ...

Read more
Sipchem to start up PBT plant in first quarter of 2015

RIYADH, SAUDI ARABIA: Saudi International Petrochemical Co (Sipchem) said the initial start-up of its new polybutylene terephthalate (PBT) plant will ...

Read more